FIELD: pharmacy.
SUBSTANCE: invention proposes a medicinal agent for oral administration possessing an anti-inflammatory effect. Medicinal agent is made as a solid dosed formulation for oral administration that comprises meloxicam as an active substance, stearic acid or stearate as a slipping substance, maltodextrin as a binding agent, croscarmellose sodium salt as a disintegrating agent and dextrin as a filling agent taken in the definite ratio of components. Invention provides enhancing the biological availability of agent and improving its consumption properties. Invention can be used in the development of a medicinal agent made as a solid dosed formulation for oral administration possessing an anti-inflammatory effect.
EFFECT: improved and valuable pharmaceutical properties of agent.
10 cl, 11 tbl, 32 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF FABOMOTIZOLE DIHYDROCHLORIDE | 2022 |
|
RU2828872C2 |
| PHARMACEUTICAL COMPOSITION OF N-(6-PHENYLHEXANOYL)GLYCYL-L-TRYPTOPHAN AMIDE WITH FILM COATING AND THE METHOD OF ITS PRODUCTION | 2013 |
|
RU2663691C2 |
| COMPOSITION WITH HEPATOPROTECTIVE AND METABOLISM NORMALIZING ACTIVITY | 2005 |
|
RU2283114C1 |
| AGENT FOR TREATMENT OF PROSTATE DISEASE | 2005 |
|
RU2278681C1 |
| PHARMACEUTICAL COMPOSITION HAVING IMMUNOSTIMULATING ACTION | 2015 |
|
RU2605832C2 |
| PHARMACEUTICAL COMPOSITION OF N-(6-PHENYLHEXANOYL)GLYCYL-L-TRYPTOPHAN AMIDE IN SOLID DOSAGE FORM | 2013 |
|
RU2602742C2 |
| SOLID MEDICINAL FORM INTENDED FOR TREATMENT OF ARTERIAL HYPERTENSIA AND STENOCARDIA, AND WAY OF ITS RECEPTION | 2008 |
|
RU2359672C1 |
| COMPOSITION AND METHOD FOR PRODUCING A SOLID DOSAGE FORM CONTAINING (Z)-3-(2-OXO-2-(4-TOLYL)ETHYLIDENE)PIPERAZIN-2-ONE | 2017 |
|
RU2657526C1 |
| TREATMENT-AND-PREVENTIVE AGENT OF ANTIBACTERIAL AND SPERMICIDAL ACTION | 2006 |
|
RU2329790C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
